{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:54:13Z","timestamp":1792709653387,"version":"4.5.0"},"reference-count":40,"publisher":"Japanese Association for Laboratory Animal Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1538\/expanim.16-0013","type":"journal-article","created":{"date-parts":[[2016,6,5]],"date-time":"2016-06-05T22:03:33Z","timestamp":1465164213000},"page":"373-382","source":"Crossref","is-referenced-by-count":4,"title":["An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice"],"prefix":"10.1538","volume":"65","author":[{"given":"Lunzhi","family":"Yuan","sequence":"first","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China"},{"name":"National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengyun","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China"},{"name":"National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China"},{"name":"National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China"},{"name":"National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianying","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China"},{"name":"National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China"},{"name":"National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingguo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Zhongshan Hospital of Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China"},{"name":"National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Wai Kuo","family":"Shih","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China"},{"name":"National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Yuan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China"},{"name":"National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China"},{"name":"National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China"},{"name":"National Institute of Diagnostics and Vaccine Development in infectious diseases, School of Public Health, Xiamen University, Xiamen 361102, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Almog Y., Klein A., Adler R., Laub O., and Tur-Kaspa R. 1992. Estrogen suppresses hepatitis B virus expression in male athymic mice transplanted with HBV transfected Hep G-2 cells. <i>Antiviral Res.<\/i> 19: 285\u2013293.","DOI":"10.1016\/0166-3542(92)90010-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Araki K., Miyazaki J., Hino O., Tomita N., Chisaka O., Matsubara K., and Yamamura K. 1989. Expression and replication of hepatitis B virus genome in transgenic mice. <i>Proc. Natl. Acad. Sci. USA<\/i> 86: 207\u2013211.","DOI":"10.1073\/pnas.86.1.207"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Ben-Ari Z., Mor E., Papo O., Kfir B., Sulkes J., Tambur A.R., Tur-Kaspa R., and Klein T. 2003. Cytokine gene polymorphisms in patients infected with hepatitis B virus. <i>Am. J. Gastroenterol.<\/i> 98: 144\u2013150.","DOI":"10.1111\/j.1572-0241.2003.07179.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chang W.W., Su I.J., Lai M.D., Chang W.T., Huang W., and Lei H.Y. 2003. The role of inducible nitric oxide synthase in a murine acute hepatitis B virus (HBV) infection model induced by hydrodynamics-based in vivo transfection of HBV-DNA. <i>J. Hepatol.<\/i> 39: 834\u2013842.","DOI":"10.1016\/S0168-8278(03)00389-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chen C.J., Yang H.I., Su J., Jen C.L., You S.L., Lu S.N., Huang G.T., Iloeje U.H., REVEAL-HBV Study Group 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. <i>JAMA<\/i> 295: 65\u201373.","DOI":"10.1001\/jama.295.1.65"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chen D.S. 1993. Natural history of chronic hepatitis B virus infection: new light on an old story. <i>J. Gastroenterol. Hepatol.<\/i> 8: 470\u2013475.","DOI":"10.1111\/j.1440-1746.1993.tb01551.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Chen S.H., Wu H.L., Kao J.H., and Hwang L.H. 2012. Persistent hepatitis B viral replication in a FVB\/N mouse model: impact of host and viral factors. <i>PLoS ONE<\/i> 7: e36984.","DOI":"10.1371\/journal.pone.0036984"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chen Z.Y., He C.Y., Meuse L., and Kay M.A. 2004. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. <i>Gene Ther.<\/i> 11: 856\u2013864.","DOI":"10.1038\/sj.gt.3302231"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chisari F.V. 1995. Hepatitis B virus transgenic mice: insights into the virus and the disease. <i>Hepatology<\/i> 22: 1316\u20131325.","DOI":"10.1002\/hep.1840220443"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cort\u00e9s M.L., Oehmig A., Saydam O., Sanford J.D., Perry K.F., Fraefel C., and Breakefield X.O. 2008. Targeted integration of functional human ATM cDNA into genome mediated by HSV\/AAV hybrid amplicon vector. <i>Mol. Ther.<\/i> 16: 81\u201388.","DOI":"10.1038\/sj.mt.6300338"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Deng G., Zhou G., Zhai Y., Li S., Li X., Li Y., Zhang R., Yao Z., Shen Y., Qiang B., Wang Y., and He F. 2004. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. <i>Hepatology<\/i> 40: 318\u2013326.","DOI":"10.1002\/hep.20318"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Giladi H., Ketzinel-Gilad M., Rivkin L., Felig Y., Nussbaum O., and Galun E. 2003. Small interfering RNA inhibits hepatitis B virus replication in mice. <i>Mol. Ther.<\/i> 8: 769\u2013776.","DOI":"10.1016\/S1525-0016(03)00244-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Glover D.J., Lipps H.J., and Jans D.A. 2005. Towards safe, non-viral therapeutic gene expression in humans. <i>Nat. Rev. Genet.<\/i> 6: 299\u2013310.","DOI":"10.1038\/nrg1577"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Han J., Ding L., Yuan B., Yang X., Wang X., Li J., Lu Q., Huang C., and Ye Q. 2006. Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells. <i>Nucleic Acids Res.<\/i> 34: 3095\u20133106.","DOI":"10.1093\/nar\/gkl389"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hibbitt O.C., Harbottle R.P., Waddington S.N., Bursill C.A., Coutelle C., Channon K.M., and Wade-Martins R. 2007. Delivery and long-term expression of a 135 kb LDLR genomic DNA locus in vivo by hydrodynamic tail vein injection. <i>J. Gene Med.<\/i> 9: 488\u2013497.","DOI":"10.1002\/jgm.1041"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Huang L.R., Wu H.L., Chen P.J., and Chen D.S. 2006. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. <i>Proc. Natl. Acad. Sci. USA<\/i> 103: 17862\u201317867.","DOI":"10.1073\/pnas.0608578103"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ince W.L., Zhang L., Jiang Q., Arrildt K., Su L., and Swanstrom R. 2010. Evolution of the HIV-1 env gene in the Rag2<sup>-\/-<\/sup> gammaC<sup>-\/-<\/sup> humanized mouse model. <i>J. Virol.<\/i> 84: 2740\u20132752.","DOI":"10.1128\/JVI.02180-09"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Bakowska J.C., Di Maria M.V., Camp S.M., Wang Y., Allen P.D., and Breakefield X.O. 2003. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV\/AAV rep(+) hybrid amplicon vector. <i>Gene Ther.<\/i> 10: 1691\u20131702.","DOI":"10.1038\/sj.gt.3302061"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jin Z., Sun R., Wei H., Gao X., Chen Y., and Tian Z. 2011. Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells. <i>Hepatology<\/i> 53: 219\u2013229.","DOI":"10.1002\/hep.23983"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ketzinel-Gilad M., Zauberman A., Nussbaum O., Shoshany Y., Ben-Moshe O., Pappo O., Felig Y., Ilan E., Wald H., Dagan S., and Galun E. 2006. The use of the hydrodynamic HBV animal model to study HBV biology and anti-viral therapy. <i>Hepatol. Res.<\/i> 34: 228\u2013237.","DOI":"10.1016\/j.hepres.2006.01.008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lavanchy D. 2005. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. <i>J. Clin. Virol.<\/i> 34:(Suppl 1): S1\u2013S3.","DOI":"10.1016\/S1386-6532(05)00384-7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lavanchy D. 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. <i>J. Viral Hepat.<\/i> 11: 97\u2013107.","DOI":"10.1046\/j.1365-2893.2003.00487.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Liu R., Li Y., Hu R., Jin T., Deng S., Liang W., Zhang N., Chen J., Prud\u2019homme G.J., Jia W.W., Ma D., and Wang Q. 2010. A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasis. <i>Biochem. Biophys. Res. Commun.<\/i> 403: 172\u2013177.","DOI":"10.1016\/j.bbrc.2010.10.131"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Llovet J.M., Burroughs A., and Bruix J. 2003. Hepatocellular carcinoma. <i>Lancet<\/i> 362: 1907\u20131917.","DOI":"10.1016\/S0140-6736(03)14964-1"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. McMahon B.J. 2009. The natural history of chronic hepatitis B virus infection. <i>Hepatology<\/i> 49:(Suppl): S45\u2013S55.","DOI":"10.1002\/hep.22898"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Miao C.H., Thompson A.R., Loeb K., and Ye X. 2001. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. <i>Mol. Ther.<\/i> 3: 947\u2013957.","DOI":"10.1006\/mthe.2001.0333"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Moriyama T., Guilhot S., Klopchin K., Moss B., Pinkert C.A., Palmiter R.D., Brinster R.L., Kanagawa O., and Chisari F.V. 1990. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. <i>Science<\/i> 248: 361\u2013364.","DOI":"10.1126\/science.1691527"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A.M., and Karin M. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. <i>Science<\/i> 317: 121\u2013124.","DOI":"10.1126\/science.1140485"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Qi Z., Li G., Hu H., Yang C., Zhang X., Leng Q., Xie Y., Yu D., Zhang X., Gao Y., Lan K., and Deng Q. 2014. Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice. <i>J. Virol.<\/i> 88: 8045\u20138056.","DOI":"10.1128\/JVI.01024-14"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Riu E., Grimm D., Huang Z., and Kay M.A. 2005. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo. <i>Hum. Gene Ther.<\/i> 16: 558\u2013570.","DOI":"10.1089\/hum.2005.16.558"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Thursz M. 2001. Genetic susceptibility in chronic viral hepatitis. <i>Antiviral Res.<\/i> 52: 113\u2013116.","DOI":"10.1016\/S0166-3542(01)00175-9"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Tian Y., Kuo C.F., Chen W.L., and Ou J.H. 2012. Enhancement of hepatitis B virus replication by androgen and its receptor in mice. <i>J. Virol.<\/i> 86: 1904\u20131910.","DOI":"10.1128\/JVI.06707-11"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wang J., Wang B., Huang S., Song Z., Wu J., Zhang E., Zhu Z., Zhu B., Yin Y., Lin Y., Xu Y., Zheng X., Lu M., and Yang D. 2014. Immunosuppressive drugs modulate the replication of hepatitis B virus (HBV) in a hydrodynamic injection mouse model. <i>PLOS ONE<\/i> 9: e85832.","DOI":"10.1371\/journal.pone.0085832"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Wang S.H., Yeh S.H., Lin W.H., Wang H.Y., Chen D.S., and Chen P.J. 2009. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. <i>Hepatology<\/i> 50: 1392\u20131402.","DOI":"10.1002\/hep.23163"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Wooddell C.I., Reppen T., Wolff J.A., and Herweijer H. 2008. Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery. <i>J. Gene Med.<\/i> 10: 551\u2013563.","DOI":"10.1002\/jgm.1179"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Yang P.L., Althage A., Chung J., and Chisari F.V. 2002. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. <i>Proc. Natl. Acad. Sci. USA<\/i> 99: 13825\u201313830.","DOI":"10.1073\/pnas.202398599"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Yu M.W., Chang H.C., Liaw Y.F., Lin S.M., Lee S.D., Liu C.J., Chen P.J., Hsiao T.J., Lee P.H., and Chen C.J. 2000. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. <i>J. Natl. Cancer Inst.<\/i> 92: 1159\u20131164.","DOI":"10.1093\/jnci\/92.14.1159"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Zhang L. and Su L. 2012. HIV-1 immunopathogenesis in humanized mouse models. <i>Cell. Mol. Immunol.<\/i> 9: 237\u2013244.","DOI":"10.1038\/cmi.2012.7"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Zhang Y.L., Cheng T., Cai Y.J., Yuan Q., Liu C., Zhang T., Xia D.Z., Li R.Y., Yang L.W., Wang Y.B., Yeo A.E., Shih J.W., Zhang J., and Xia N.S. 2010. RNA Interference inhibits hepatitis B virus of different genotypes in vitro and in vivo. <i>BMC Microbiol.<\/i> 10: 214.","DOI":"10.1186\/1471-2180-10-214"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Zhi-ming L., Yu-lian J., Zhao-lei F., Chun-xiao W., Zhen-fang D., Bing-chang Z., and Yue-ran Z. 2007. Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population. <i>Croat. Med. J.<\/i> 48: 800\u2013806.","DOI":"10.3325\/cmj.2007.6.800"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/65\/4\/65_16-0013\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T08:23:28Z","timestamp":1568017408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/65\/4\/65_16-0013\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.16-0013","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}